Frontiers in Oncology | Pediatric Oncology

Review

Published on 16 Jan 2023

Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type

in Pediatric Oncology

Stefano Gabriele Vallero
Luca Bertero
Giovanni Morana
Paola Sciortino
Daniele Bertin
Anna Mussano
Federica Silvia Ricci
Paola Peretta
Franca Fagioli

Frontiers in Oncology

doi 10.3389/fonc.2022.1082062

21,826 views
51 citations

Original Research

Published on 13 Jan 2023

Study on differentially expressed genes between stage M and stage MS neuroblastoma

in Pediatric Oncology

Yuying Wu
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1083570

3,271 views
4 citations

Case Report

Published on 12 Jan 2023

Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors

in Pediatric Oncology

Rostislav Skitchenko
Yulia Dinikina
Sergey Smirnov
Mikhail Krapivin
Anna Smirnova
Daria Morgacheva
Mykyta Artomov

Frontiers in Oncology

doi 10.3389/fonc.2022.1085947

4,127 views
2 citations

Original Research

Published on 11 Jan 2023

Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections

in Pediatric Oncology

Daniel N. Willis
Mary Claire McGlynn
Patrick J. Reich
Robert J. Hayashi

Frontiers in Oncology

doi 10.3389/fonc.2022.1063253

2,982 views
7 citations

Mini Review

Published on 10 Jan 2023

Recent advances in the roles of exosomal microRNAs in neuroblastoma

in Pediatric Oncology

Swapnil Parashram Bhavsar

Frontiers in Oncology

doi 10.3389/fonc.2022.1091847

3,432 views
8 citations

Original Research

Published on 09 Jan 2023

Genetic variants in m5C modification core genes are associated with the risk of Chinese pediatric acute lymphoblastic leukemia: A five-center case–control study

in Pediatric Oncology

Xueliang Wang
Decheng Deng
Yaping Yan
Mansi Cai
Xiaodan Liu
Ailing Luo
Shanshan Liu
Xiaohong Zhang
Hua Jiang
Xiaoping Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1082525

3,759 views
5 citations

Review

Published on 06 Jan 2023

Chromatin mutations in pediatric high grade gliomas

in Pediatric Oncology

Hsiao P. J. Voon
Lee H. Wong

Frontiers in Oncology

doi 10.3389/fonc.2022.1104129

4,777 views
6 citations

Original Research

Published on 05 Jan 2023

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

in Pediatric Oncology

Christina Fong
Brian H. Kushner
Angela Di Giannatale
Gunes Gundem
Shanita Li
Stephen S. Roberts
Ellen M. Basu
Anita Price
Nai-Kong V. Cheung
Shakeel Modak

Frontiers in Oncology

doi 10.3389/fonc.2022.1106597

2,731 views
2 citations

Case Report

Published on 04 Jan 2023

Case report: Clinical features and prognosis of two Infants with rhabdomyosarcoma of the tongue

in Pediatric Oncology

Peiyi Yang
Na Xu
Yan Su
Chao Duan
Shengcai Wang
Libing Fu
Tong Yu
Ruolan Guo
Xiaoli Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.934882

3,638 views
2 citations

Original Research

Published on 23 Dec 2022

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience

in Pediatric Oncology

Nur Olgun
Emre Cecen
Dilek Ince
Deniz Kizmazoglu
Birsen Baysal
Ayse Onal
Ozhan Ozdogan
Handan Guleryuz
Riza Cetingoz
Ayse Demiral

Frontiers in Oncology

doi 10.3389/fonc.2022.1041443

8,473 views
23 citations

Original Research

Published on 15 Dec 2022

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma

in Pediatric Oncology

Zheng Fu
Jiazhong Ren
Jing Zhou
Junkang Shen

Frontiers in Oncology

doi 10.3389/fonc.2022.1031078

3,404 views
4 citations

Original Research

Published on 08 Dec 2022

Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry

in Pediatric Oncology

Lucia Lisa Petrilli
Claudia Fuoco
Alessandro Palma
Luca Pasquini
Giulia Pericoli
Yura Grabovska
Alan Mackay
Sabrina Rossi
Angel M. Carcaboso
Andrea Carai

Frontiers in Oncology

doi 10.3389/fonc.2022.1016343

5,804 views
9 citations

Original Research

Published on 01 Dec 2022

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients

in Pediatric Oncology

Jing Wang
Xinyao Meng
Ke Chen
Jiexiong Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.1014845

1,986 views

Mini Review

Published on 30 Nov 2022

Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children

in Pediatric Oncology

Roberto Rivera-Luna
Patricia Perez-Vera
Cesar Galvan-Diaz
Liliana Velasco-Hidalgo
Alberto Olaya-Vargas
Rocio Cardenas-Cardos
Marco Aguilar-Ortiz
Jesus Ponce-Cruz

Frontiers in Oncology

doi 10.3389/fonc.2022.1072811

5,597 views
14 citations

Original Research

Published on 30 Nov 2022

Outcomes for critical illness in children with cancer: Analysis of risk factors for adverse outcome and resource utilization from a specialized center in Mexico

in Pediatric Oncology

Adolfo Cardenas-Aguirre
Montserrat Hernandez-Garcia
Berenice Lira-De-Leon
Yulissa L. Munoz-Brugal
Huiqi Wang
Ivonne Villanueva-Diaz
Eduardo Ruiz-Perez
Jose M. Mijares-Tobias
Alex O. Giles-Gonzalez
Jennifer McArthur

Frontiers in Oncology

doi 10.3389/fonc.2022.1038879

3,247 views
3 citations

Mini Review

Published on 29 Nov 2022

Management of infantile hemangiomas: Recent advances

in Pediatric Oncology

Wei Xu
Haiguang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.1064048

8,586 views
17 citations

Perspective

Published on 29 Nov 2022

Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients

in Pediatric Oncology

Agnes Reschke
Rebecca M. Richards
Stephanie M. Smith
Adrienne H. Long
Lianna J. Marks
Liora Schultz
Jennifer L. Kamens
Catherine Aftandilian
Kara L. Davis
Tanja Gruber

Frontiers in Oncology

doi 10.3389/fonc.2022.1033993

5,356 views
9 citations

Original Research

Published on 24 Nov 2022

Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study

in Pediatric Oncology

Zhichao Tan
Jiayong Liu
Ruifeng Xue
Zhengfu Fan
Chujie Bai
Shu Li
Tian Gao
Lu Zhang
Xinyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1019911

3,711 views
4 citations

Original Research

Published on 24 Nov 2022

Photodynamic therapy for malignant brain tumors in children and young adolescents

in Pediatric Oncology

Kentaro Chiba
Yasuo Aihara
Yuichi Oda
Atsushi Fukui
Shunsuke Tsuzuki
Taiichi Saito
Masayuki Nitta
Yoshihiro Muragaki
Takakazu Kawamata

Frontiers in Oncology

doi 10.3389/fonc.2022.957267

3,862 views
14 citations

Original Research

Published on 17 Nov 2022

Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors

in Pediatric Oncology

Margot A. Lazow
Christine Fuller
Andrew T. Trout
Joseph R. Stanek
Jaime Reuss
Brian K. Turpin
Sara Szabo
Ralph Salloum

Frontiers in Oncology

doi 10.3389/fonc.2022.996489

3,924 views
7 citations

Original Research

Published on 16 Nov 2022

Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature

in Pediatric Oncology

Mingyan Jiang
Jinrong Li
Jianrong Wu
Yiping Zhu
Ju Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.1028089

4,313 views
9 citations

Original Research

Published on 15 Nov 2022

“Finding my way in a maze while the clock is ticking”: The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis

in Pediatric Oncology

Vivian W. G. Burgers
Martin J. van den Bent
Linda Dirven
Roy I. Lalisang
Jacqueline M. Tromp
Annette Compter
Mathilde Kouwenhoven
Monique E. M. M. Bos
Adrianus de Langen
Milou J. P. Reuvers

Frontiers in Oncology

doi 10.3389/fonc.2022.994934

5,730 views
18 citations

Case Report

Published on 10 Nov 2022

Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports

in Pediatric Oncology

Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu
Xiaoyan Luo
Hua Wang
Sili Ni

Frontiers in Oncology

doi 10.3389/fonc.2022.1000099

4,236 views
2 citations

Original Research

Published on 08 Nov 2022

Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases

in Pediatric Oncology

Changfeng Wang
Jiali Sun
Lei Guo
Dan Song
Xin Zhang
Zhuang Liu
Liang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1014465

3,751 views
9 citations

665 articles

articles

Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type

Study on differentially expressed genes between stage M and stage MS neuroblastoma

Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors

Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections

Recent advances in the roles of exosomal microRNAs in neuroblastoma

Genetic variants in m5C modification core genes are associated with the risk of Chinese pediatric acute lymphoblastic leukemia: A five-center case–control study

Chromatin mutations in pediatric high grade gliomas

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

Case report: Clinical features and prognosis of two Infants with rhabdomyosarcoma of the tongue

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma

Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients

Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children

Outcomes for critical illness in children with cancer: Analysis of risk factors for adverse outcome and resource utilization from a specialized center in Mexico

Management of infantile hemangiomas: Recent advances

Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients

Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study

Photodynamic therapy for malignant brain tumors in children and young adolescents

Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors

Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature

“Finding my way in a maze while the clock is ticking”: The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis

Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports

Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases